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Abstract
Background Dietary supplements and herbal medicines are
gaining popularity in many developed countries.
Aims Although most can be used without any problem,
serious toxicities do occur.
Methods Problems can be anticipated when they are used
for non-traditional indications, at excessive dose, for
prolonged duration, or by patients who are also on multiple
modern pharmaceuticals. Problems should also be antici-
pated when these products claim to be able to relieve
symptoms rapidly or when herbs with pronounced pharma-
cological effects or toxic components are used.
Results Resuscitation, symptomatic and supportive care are
the most important aspects of management of toxicities
from these products.
Conclusion This article reviews when problems with these
products can be anticipated and outlines a practical approach
to management.
Keywords Dietary supplements . Herbals . Toxicity .
Poisoning . Drug contamination . Herb-drug interaction
Introduction
Dietary supplements and herbal medicines play important
roles in health care. Vitamins and minerals are important,
as they are necessary for enzymatic reactions and bodily
functions; lack of these compounds can lead to deficiency-
related diseases. Herbal medicine was the predominant
form of health care for the world’s population before the
advent of modern medicine and still is the predominant
form of health care in many underserved populations.
Herbal medicine continues to infuse new ideas and
treatments into modern medicine for the benefit of our
patients.
According to the 2006 American Association of Poison
Control Center (AAPCC) data, there were a total of
972,073 exposures to pharmaceutical products resulting in
adverse events, of which there were 6,809 major outcomes
and 507 deaths [1]. Of these exposures, 76,364 (7.9%)
were due to dietary supplements and vitamins, with 42
major outcomes (0.6% of all major outcomes) and only 3
deaths (0.6% of all deaths). Hence, serious adverse effects
and death from these products are relatively uncommon. A
review of hospital admissions in Hong Kong found only
0.2% of the cases were due to adverse reactions from
herbal products [2]. A London unit had 5,536 enquiries on
traditional medicines and food supplement exposures from
1983 to 1991, and only 12% of the patients were
symptomatic [3]. Despite the prevalent use of these
products, adverse outcome and death only arise occasion-
ally. It is safe to conclude that in most instances, dietary
supplements and herbal medicines are relatively harmless
when used appropriately.
Nevertheless, there are many reports in the literature
that suggest that unnecessary or reckless use of these
products can lead to problems. We see two major issues
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that contribute to these problems: A public perception that
these products are inherently safe, and the lack of
knowledge about these products in the medical profession.
This article reviews the toxicities described in the
literature associated with their use and when to anticipate
problems with them, and describes an approach that an
emergency physician can adopt when he or she encounters
patients with such toxicities.
Definitions
The World Health Organization (WHO) and the United
States (US) Dietary Supplements Health and Education Act
(DSHEA) of 1994 both define dietary supplements as a
product (other than tobacco) that is meant to supplement the
diet. Both organizations include vitamins, minerals, herbs,
botanical products, amino acids, or dietary substances in
their definitions [4].
The WHO also defines herbal medicines as plant-derived
materials or preparations intended for human therapeutic
use or for other health benefits in humans [4]. However,
most indigenous herbal traditions not only have plant
matters in their material medica, but also include animal
matters and mineral compounds. Herbal products are
usually ingested raw, as tea or as decoctions (concentrated
extracts). Sometimes they are applied as a paste or powder
on the skin. Some herbal traditions, such as traditional
Chinese Mmdicine (TCM) and Ayurvedic medicine, have
medicinal products that are packaged in the form of pills or
liquids for ease of consumption and retailing [5]. These are
sometimes called proprietary medicine, finished products,
or patent medicine.
When to anticipate adverse effects and toxicities
Certain patterns of use or use of certain products tend to
produce adverse effects and toxicities. Table 1 outlines
when problems can be anticipated.
In most instances, problems arise due to inappropriate
usage of these herbs and supplements. Herbs and supple-
ments can be toxic when used for inappropriate indications,
or prepared inappropriately, or used in large excessive
dosages, or for a prolonged duration of time. When patients
provide such a history of use, physicians should be on a
look out for possible toxicities. For example, excessive
doses of vitamin D due to overzealous fortification in milk
resulted in hypercalemia; similarly, excessive and pro-
longed intake of vitamin A can lead to osteoporosis and
hepatotoxicity [6–9].
Many serious adverse effects have arisen because of
using of traditional herbs for non-traditional indications.
Ephedra is used in small dose in TCM for indications, such
as wheezing and cough [10], but it was never used as a
stimulant, a dieting agent, or recreational agent; however,
such uses in excessive doses and durations have resulted in
serious toxicities, including death, seizures, psychosis,
myocardial infarction, cardiac arrhythmia, and stroke [11,
12]. Similarly, the use of Datura species for recreational
purposes instead of therapeutic effects has resulted in anti-
cholinergic poisoning and death [13].
In Belgium in the early 1990s, the TCM herb Stephania
tetrandra was used for weight loss. Aristolochia fangchi
was mistakenly used instead, and this resulted in more than
100 cases of renal failure and more than 20 cases of
urothelial dysplasia [9]. Similar problems were later
reported in the UK [14]. The culprit is thought to be the
Table 1 When adverse effects and toxicities may arise
Factors predisposing to adverse effects and toxicities When to anticipate them
Inappropriate usage and inherent toxicity of herbs Inappropriate indications (non-traditional indications)—weight loss, athletic
performance, recreational use
Inappropriate duration—use for prolonged periods of time, usually several weeks
to months
Inappropriate dosage—excessive dose in order to achieve some particular results
Inadequate processing—herbs that are usually consumed in a certain way in a
particular herbal tradition being processed in other non-recommended ways
Herbs with pronounced pharmacological effects or toxic components
Adulteration with modern pharmaceuticals (NSAIDs,
steroids, antihistamines, Sildenafil, sulfonylurea)
Finished products claiming fast relief of symptoms or sexual enhancement
Drug interaction Patients on multiple modern pharmaceuticals, especially drugs with a narrow
therapeutic index, such as warfarin, and taking dietary supplements and herbal
products
Patients taking multiple dietary supplements or herbal medicines
Heavy metal toxicities Finished products from TCM, Ayurvedic traditions, or Mexican folk remedies
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aristolochic acid found in Aristolochia fangchi. In TCM
practice, Stephania tetrandra and Aristolochia fangchi were
never meant to be used for weight loss [9, 15].
Inappropriate processing of herbs can also result in
problems. In TCM practice, Aristolochia fangchi requires
extensive boiling into a decoction before being applied in
small amounts. In the Belgian sliming clinic, it was used as
a powder. Aristolochic acid concentration is much lower in
decoctions as it has low water solubility; hence, a decoction
is a safer way to administer it [5, 10].
Herbal medicines do not usually produce immediate
relief of symptoms as most of them are generally concerned
with homeostasis. When products claim to provide imme-
diate relieve of symptoms, physicians should watch out for
possible intentional adulteration with pharmaceuticals.
Such adulterations can cause problems and toxicities. These
products are usually in the form of finished products meant
for ingestion or occasionally for topical applications. A
survey in Taiwan found that of 2,609 herbal samples
analyzed, 23.7% were adulterated with pharmaceuticals
[16]. A study of 243 proprietary products in California
found that 7% contained undeclared pharmaceuticals [5]. In
1999, out of 3,320 TCM herbal products screened in
Singapore, 1.2% were found to contain undeclared phar-
maceuticals [17, 18]. Usually only one adulterant is found,
although there are instances of multiple adulterants.
Another form of adulteration is the substitution of one herb
for another that may be cheaper or more readily available,
but has a less desirable safety profile.
The most common adulterants are pharmaceuticals that are
used to relieve uncomfortable symptoms, such as non-steroidal
anti-inflammatory drugs (NSAIDs) and antihistamines [5, 9,
16]. Adulteration in steroids and sexual-enhancing drugs,
such as Sildenafil, are also commonly reported [17, 18].
Serious adverse effects including death can result from such
adulterations, especially since the drugs added can have
serious toxic effects; for example, sulfonylurea, phenylbuta-
zone, phenytoin, and corticosteroids can have serious toxic
effects [19]. Problems that can arise from adulterants in
these products include allergic reactions, Addisonian
crisis, and Cushing’s syndrome from unsuspecting use of
products with added steroids [20]. Hypotension can occur
in patients on nitrates for cardiac ischemia and unsuspect-
ed use of products adulterated with Sildenafil, and severe
or fatal hypoglycemia can result from unsuspected use of
products with sulfonylurea.
For patients taking multiple medications and dietary
supplements or herbal medicines, physicians should look
out for herb-drug interactions. Sixteen percent of adults in
US who take prescription medicine also take herbal
medicines [21]. Patients with chronic illnesses, who are
most likely to be taking multiple medications, are also most
likely to consume dietary supplements or herbal medica-
tions, putting them at risk of drug-herb interactions [22].
Patients may consume multiple dietary supplements or
herbal medicines and take products that contain multiple
components, putting themselves at risk of herb-herb
interactions.
Patients most at risk of harmful drug-herbs interactions
are those at extremes of age, on multiple prescriptions, with
chronic illnesses or with impaired organ functions and
those on prescription medications with a narrow therapeutic
margin, such as warfarin [23]. Coagulative problems arising
from drug-herb interactions with warfarin are commonly
reported, sometimes with serious consequences, such as
intracranial hematoma [24]. Garlic, gingko, ginger, and
Angelica sinensis (Dong quai) are commonly implicated as
they are commonly used, but any herb that may contain
compounds related to salicylate or coumarin can augment
anti-coagulative effects, resulting in bleeding [22].
Augmentation of sedative effects of modern pharma-
ceuticals is another problem, especially with popular herbs
with sedative effects, such as Piper methysticum (kava) and
Valeriana officinalis (valerian). Kava has been reported to
increase the frequency and duration of “off-periods” in
Parkinson’s patients, and long-term use of this herb can also
lead to hepatotoxicity and dermatopathy [24, 25]. Another
form of interaction is with metabolic enzymes. For
example,Hypericum perforatum (St John’s wort), popularly
used as an herbal anti-depressant, is a strong inducer of
CYP3A, which metabolizes about 50% of all modern
pharmaceuticals. This induction can lead to a sub-
therapeutic effect in drugs that are inactivated or potential
toxic effects in drugs that are activated by this family of
enzymes [22].
Contamination of dietary supplements and herbal med-
icines with unwanted substances is another area of concern.
Problems arising from contaminations are difficult to
anticipate except that they appear to be more widely
reported with products from some herbal traditions, such
as TCM, Ayurvedic practices, and Mexican folk remedies.
Physicians need to be aware of this problem when they
encounter patients using products of these herbal traditions
and presenting with non-specific symptoms. One form of
contamination that is often reported is heavy metal
contamination; it can lead to heavy metal poisoning and
should be suspected in patients presenting with features
suggestive of heavy metal toxicities after using dietary
supplements and herbal medicines [26–28]. Heavy metal
contamination arises due to defective manufacturing pro-
cesses or because the herbs were grown in polluted soil
[27]. However, in some instances, like in TCM and
Ayurvedic medicine, heavy metals exist as part of their
formulary and are deliberately added into preparations for
therapeutic effects [5, 27]. Lead poisoning is frequently
reported and presents with anemia, abdominal pain, and
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encephalopathy. It is reported in children given Mexican
folk remedies for gastrointestinal symptoms [29–31] and
also in calcium supplements derived from animal sources
[32–34]. Mercury, arsenic, and thallium use are reported in
TCM [17, 18, 35]. Arsenic poisoning from herbal medicine
is usually chronic and presents with features, such as skin
changes, leucopenia, anemia, sensory neuropathy, and
malignancies [18]. Other heavy metals reported to contam-
inate dietary supplements and herbal products include,
cadmium, copper and molybdenum [27, 36, 37].
Other contaminants include micro-organisms, pesticides,
industrial chemicals, and toxic herbs. These usually result
in gastroenteritis, but more severe problems have been
reported, such as eosinophilia-myalgia syndrome and death
due to unknown chemical contamination of L-tryptophan
supplements [9, 38–40]. Chinese herbal products have been
reported to be contaminated with toxic herbs such as
podophyllum and Datura metel [41]. These can produce
features of toxicities due to the inherent toxicities of these
herbal contaminants; for example, podophyllum poisoning
can lead to agranulocytosis, and Datura ingestion can lead
to anti-cholinergic toxicities [41].
Dietary supplements and herbs that possess pronounced
pharmacological effects or toxic constituents can be
inherently poisonous, and physicians should anticipate
problems with such toxicities if they encounter patients
using these products. The clinical features encountered will
depend on the inherent compounds present in the products.
Table 2 outlines some of the frequently reported herbs and
their expected toxicities. Toxic herbs frequently encoun-
tered in reports are those with stimulant effects, such as
Ephedra species, caffeine, ginseng, and gingko; those with
cardiac effects, such as herbs containing cardioactive
glycosides or Aconitum species; those with autonomic
effects, such as Datura species, Lobelia species, and
yohimbine; those with hepatotoxic effects, such as herbs
with pyrrolizidine alkaloids; those with nephrotoxic effects,
such as herbs with aristolochic acid; and those that are used
as abortifacients, such as pennyroyal oil [5, 9, 15, 36, 42–
46].
The problem of the inherent toxicity is compounded by
the variation in content of the active ingredients found in
these products. The chemical constituents in a plant are
dependent on the soil they are grown in, rainfall and
sunshine, the season of harvesting, the stage of the plant
growth during harvest, diseases afflicting it, and the parts
that were harvested. Even in finished products, such as pills
and liquids, there can be large batch-to-batch variations in
content, and this can result in toxicity. For example, a
survey of ginseng products found up to 200 times variation
in content between different products. In another survey of
Ephedra products, within the same product, up to ten times
variation in active ingredients among batches was found
[47, 48].
Allergic reactions to dietary supplements and herbal
medicines appear to be common and under-reported [49].
These reactions may present as mild reactions, such as
pruritus and urticaria, to more severe reactions, such as
angioedema and anaphylaxis. Patients may react to com-
pounds inherent in the dietary supplements and herbal
medicines, such as proteins found in animal products.
Patients may also develop allergic reactions to compounds
that were added into these products as intentional adulter-
ants or contaminants. It is difficult to anticipate allergic
Table 2 Organ toxicities and toxidromes, and common dietary supplements or herbal medicines that can cause them
Clinical features Xenobiotics
Cardiac Sodium channel effects—Aconitum species (widen QRS, shock)
Digoxin-like effects—Digitalis species, bufo toads
Central nervous system Seizures—strychnine, thujone, essential oils (camphor, eucalyptus)
Sedation—Valeriana species, kava kava
Dermatological Blistering—cantharidin (Chinese blister beetle)
Hematological Coagulopathies—G-herbs (ginger, garlic, gingko)
Agranulocytosis—anti-mitotic agents (colchicine, podophyllotoxin)
Hepatotoxic Hepatitis—multiple agents, germander commonly reported
Veno-occlusive disease—pyrrolizidine alkaloids (comfrey, Senecio species, Heliotropium species)
Nephrotoxic Renal failure—Aristolochia speices
Hypertension, hyperkalemia—licorice
Anticholinergic Datura metel commonly used in TCM
Hexing herbs (Atropa sepcies, Hyoscyamus species, Mandrago officinarum) common in Western herbal practice
Sympathomimetic Ephedra species, Citrus aurantium (bitter orange)
Salicylate poisoning Willow bark, checkerberry
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reactions to these products unless previous allergies are
known.
Management of patient with toxicities
Toxicities from dietary supplements and herbal medicines
present unique management challenges. Patients may not
inform their physicians about herbal supplement use because
they do not perceive these products as medications. When
toxicities arise, patients may not be aware that the dietary
supplements or herbal products are causing the problems, so
they continue to use the products. Such behaviors can
hamper diagnosis or make the toxicities worse.
Information about product content and dose may also be
difficult to obtain. Labeling of these products can be inaccurate
or incomplete. The quantity of content can be different from
the label given the lack of quality assurance and labeling
consistency. Multiple components within a product make
identification of the offending agent difficult. Unsuspected
adulterants or contaminations maymake the presentation more
confusing. Raw herbs, dried herbs, or herbs processed into
powders or liquids may prove difficult or impossible to
identify. Even when labeling is accurate or herbs can be
identified, scientific and toxicological information regarding
them may not be readily available from conventional
resources. A study in the US of adverse effects from dietary
supplements found that less than half of the products or
ingredients were listed in the poison information software that
is used in most US poison centers [50].
Nevertheless, the spectrum of toxicities from dietary
supplements and herbal medicines is similar to that of
toxicities from pharmaceuticals in that similar organ system
effects or toxidromes can be expected. Furthermore, some
herbs or formulations are well known to result in certain
organ toxicities or toxidromes, and their presence should be
suspected when these clinical features occur (see Table 2).
The approach to patients with toxicities from dietary
supplements and herbal medicine is similar to the approach
to patients with other forms of toxicities. Table 3 outlines
steps generally recommended by authors for treating these
patients [22, 51]. Patients who present with unstable
medical conditions, such as cardiac dysrhythmias or
seizures, require immediate stabilization. Once they are
stabilized, extended history taking, physical examination,
and laboratory investigation can be done. Once the problem
is identified, the use of the product can be stopped or
altered, and appropriate therapy can be initiated.
Good resuscitative, symptomatic, and supportive care is
paramount in these patients, as in all patients with
poisoning. In such circumstances, offending agents would
most likely not be identified early, and even if identified,
specific antidote treatment may not exist, making resusci-
tative, symptomatic, and supportive care more important.
Some generalizations for management can be made.
Patients who present early with toxic ingestion of dietary
supplements or herbal products that can cause severe life-
threatening effects, such as Aconitium species or colchi-
cines, should undergo gastric lavage with adequate airway
protection. Similarly, activated charcoal can be given in an
acute overdose of toxic dietary supplements and herbal
medicines if there is adequate airway protection. In patients
with stimulant effects, agitation or seizures can be managed
with benzodiazepines. In patients suffering from digoxin
toxicity, digoxin antibody is expected to work, but a non-
standard dose may be required. In patients with sodium
Table 3 Useful steps in managing patients with toxicities from dietary supplements or herbal medicines
1. Ask specifically regarding use of such products
2. Secure sample for identification
a. Actual herbs or product used
b. Prescription or packaging
3. Laboratory studies
a. Basic blood count, renal function, liver function, and electrocardiogram
b. Heavy metal screening if suspected or if symptoms are non-specific
c. Analysis methods exist for some herbal toxins only—colchicines (HPLC, GCMS), tropane alkaloids (GCMS, oxalate (GCMS), vinca
alkaloids (HPLC), cardioactive steroids (immunoassay)—check with local laboratory
4. Good resuscitative, symptomatic, and supportive care
5. Use antidote if appropriate
6. Instruct patients and family to stop using the product
7. Consider outpatient monitoring of renal function, liver function, and blood counts
8. Report case to regulating authority
9. Report unusual cases in the medical literature
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channel effects (wide QRS complexes, shock), sodium
bicarbonate can be used, and class IB anti-arrhythmics such
as lignocaine can be used if sodium bicarbonate fails. The
local poison information centers can be good resources to
assist with diagnostic or management issues.
When obtaining history from patients suspected of
suffering from dietary supplement or herbal medicine
toxicities, it is important to remember that patients often
do not volunteer information regarding the use of these
products to their physicians. When suspected, physicians
need to ask patients specifically if they were or currently
are consuming such products. And these products include
specialty teas for weight loss or calming effects. Studies
have shown that up to 70% of patients who use alternative
therapies do not inform their physicians about it [52].
During physical examination, features suggestive of
toxidromes should be looked for, such as pupils size, mucosa
moisture, skin moisture, and bowel sounds. Features of
organ toxicities should also be sought, especially signs of
liver injuries or failure. These toxidromes and organ
toxicities can often be related to certain commonly used
dietary supplements and herbal medicines (see Table 2).
Whenever possible, a sample of the actual product used
by the patient should be secured; otherwise, prescription or
packaging should be secured. If this is not possible,
samples from where the patient actually obtained the
product may be useful. If raw herbs were involved, obtain
information about the parts used and how they were
processed. These can be used to identify offending agents.
Although immediate identification or analysis is often not
possible, efforts should still be made to identify them later
as some herbs and products can have long-term effects,
such as hepatotoxicity or nephrotoxicity.
Basic diagnostic studies, such as blood count, electrolytes
and renal function, liver function, and electrocardiograms,
should be performed, as well as other tests based on the
patient’s clinical presentation. If symptoms are non-specific or
suggestive of heavy metal toxicities, a heavy metal screen
may be useful. Analytical methods exist for herbal toxins,
such as colchicines, tropane alkaloids (anti-cholinergic), vinca
alkaloids, and cardioactive glycosides[53]; however, the
availability of these tests depends on local laboratories.
When such analyses are indicated, it is essential to check
with the local laboratory if the tests are available. The
salicylate level should be available in most laboratories.
For patients who can be discharged, they should be
specifically instructed to stop using the dietary supplements
or herbal medicines[22]. This discussion should involve
family members as well, as they may be taking similar
products or be supplying them to the patients. Consider-
ation should also be given to referring patients for
outpatient monitoring of liver function, renal function, and
blood counts in a week or two, as toxicities in these organs
may be delayed and not clinically apparent. Some authors
and herbal practitioners advocate that patients using TCM
should have their liver function monitored regularly as
many herbs can cause hepatotoxicity [36].
The relevant regulating authorities should be informed of
such events so that offending products can be investigated
and if necessary taken off the market to prevent more
people from being affected. The range of dietary supple-
ments and herbal products are expanding rapidly, and
medical and scientific knowledge of these products is still
growing. Unusual cases should be reported to the medical
literature to inform the medical community of potential
problems [22].
Discussing dietary supplements and herbal medicines
with patients
Opportunities arise at times to discuss the use of dietary
supplements and herbal medicines with patients or patients’
family members. Physicians trained in modern medicine
may find themselves inadequately prepared for this task;
the simplest option practiced by most physicians would
then be to denounce all such products. However, such
practice may alienate patients and their family members,
especially among ethnic groups where herbal traditions are
important. This would also cause the patients to be less
willing to approach their physicians for help when adverse
effects arise.
Ko outlined some useful advice that can be used for
patient education or discussion about dietary supplements
and herbal medicines [54]. Some advice that can be easily
committed to memory and applied in discussions is as
follows:
1. Dietary supplements and herbal medicines should be
considered as medicines. Hence, dosage recommenda-
tion should be followed, and long-term therapy should
be avoided. If unsure whether a product is safe or
useful, or if it will interact with one’s prescription,
always consult a physician or pharmacist first.
2. Obtain dietary supplements and herbal medicines from
reputable sources. The most reliable sources are large
manufacturers, especially if they are located in
countries that regulate these products like pharmaceut-
icals. This would reduce the chance that products may
contain contaminants or adulterants. If obtaining herbs,
consult an experienced herbal practitioner. In countries
where herbalists or traditional healers are licensed
legally, licensed practitioners should be consulted.
3. If new symptoms developed during the use of these
products, stop using the product and consult a
physician.
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4. Vulnerable patients, such as women who are pregnant
or nursing and young children, should avoid using
herbal medicines or dietary supplements (except folate
and iron supplements) if possible.
Conclusion
Dietary supplements and herbal medicines play an impor-
tant role in the general health-care system of many
developing countries worldwide and are gaining popularity
rapidly in many developed countries. Most of these can be
used safely if the public is given the right education and
advice. Physicians need to be ready to discuss or advise
patients with regards to their use.
Adverse effects, such as allergy, drug interactions,
heavy metal poisonings, reactions to adulterants or con-
taminants, and toxicities, can arise from the product itself.
When these problems manifest, a rational approach in
management emphasizing good resuscitation, symptomatic,
and supportive care can be helpful. Clinical features may
give clues about the offending agents. Physicians should
consider following up these patients for delayed organ-toxic
effects.
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